BioMEMS market to almost triple over the next five years, says Yole Développement

January 30, 2013 // By Julien Happich
With its latest report on “BioMEMS”, Yole Développement expects the BioMEMS market to grow rapidly, from $1.9B in 2012 to $6.6B in 2018. According to Benjamin Roussel, Technology & Market Analyst, Microfluidics & Medical Technologies at Yole Développement, microsystems integration is fast becoming a key added-value for system manufacturers.

Microsystem devices have become increasingly visible in the Healthcare market by serving as solutions adapted to the requirements of various applications. The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. For example, the introduction of accelerometers in pacemakers has revolutionized the treatment of cardiac diseases. The microsystem technologies market for healthcare applications looks promising, and should reach $6.6B by 2018.

Motivation for the acceptance of BioMEMS technologies is highly dependent on each individual market. Whereas the acceptance of microsystems is linked to sensibility and automation constraints in the Pharmaceutical market, in the in-vitro diagnostic market it's all about portability and cost reduction; while the Medical Devices market is focused on addition of functionalities. Concerning the Home Care market, the motivations are to increase system safety and connectivity. Yole Développement’s experts have identified a number of applications for each device type. These applications can be placed into five groups: patient monitoring, patient care, medical imaging, in-vitro diagnostic testing and drug delivery.

Visit Yole Developpement at www.yole.fr